Tag: Benaroya Research Institute

AR101

Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...

Aimmune plans to submit a Biologics License Application for AR101 to the FDA by the end of 2018.
Reasearcher

Institute Receives $5M Grant to Study Personalized Treatments for Peanut Allergy

What they discover could guide the design of a new strategy for immune intervention.
Research

Th2A: the Key to Unlocking Better Testing and a Cure for...

A look at what all the excitement is about.
Test Tubes

Adult Peanut Allergy: Therapy Cleared to Begin Phase IIa Trials

Antibody targets trigger also implicated in other food allergies, atopic diseases, and asthma.

Connect with Us

34,922FansLike
94FollowersFollow
197FollowersFollow
2,324FollowersFollow
5,211FollowersFollow
37SubscribersSubscribe